Nano-X Imaging (NNOX) Competitors $5.20 -0.01 (-0.10%) As of 03:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNOX vs. FNA, PLSE, BLFS, TNDM, MDXG, INMD, SSII, KMTS, IRMD, and SIBNShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Paragon 28 (FNA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), MiMedx Group (MDXG), InMode (INMD), SS Innovations International (SSII), Kestra Medical Technologies (KMTS), iRadimed (IRMD), and SiBone (SIBN). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. Its Competitors Paragon 28 Pulse Biosciences BioLife Solutions Tandem Diabetes Care MiMedx Group InMode SS Innovations International Kestra Medical Technologies iRadimed SiBone Nano-X Imaging (NASDAQ:NNOX) and Paragon 28 (NYSE:FNA) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation. Which has more risk and volatility, NNOX or FNA? Nano-X Imaging has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Do analysts rate NNOX or FNA? Nano-X Imaging presently has a consensus price target of $9.50, indicating a potential upside of 82.87%. Paragon 28 has a consensus price target of $12.75, indicating a potential downside of 2.71%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, research analysts plainly believe Nano-X Imaging is more favorable than Paragon 28.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Paragon 28 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has stronger earnings & valuation, NNOX or FNA? Nano-X Imaging has higher earnings, but lower revenue than Paragon 28. Paragon 28 is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$11.28M26.61-$53.52M-$0.90-5.77Paragon 28$256.18M4.29-$57.53M-$0.63-20.80 Do insiders & institutionals believe in NNOX or FNA? 21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 63.6% of Paragon 28 shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media favor NNOX or FNA? In the previous week, Nano-X Imaging had 2 more articles in the media than Paragon 28. MarketBeat recorded 2 mentions for Nano-X Imaging and 0 mentions for Paragon 28. Nano-X Imaging's average media sentiment score of 0.93 beat Paragon 28's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Overall Sentiment Nano-X Imaging Positive Paragon 28 Neutral Is NNOX or FNA more profitable? Paragon 28 has a net margin of -25.31% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat Paragon 28's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-472.19% -30.92% -27.73% Paragon 28 -25.31%-37.90%-18.22% SummaryNano-X Imaging beats Paragon 28 on 11 of the 17 factors compared between the two stocks. Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$300.05M$2.53B$18.98B$9.52BDividend YieldN/A1.49%2.72%3.99%P/E Ratio-5.7730.8129.5320.02Price / Sales26.6136.9851.01104.32Price / CashN/A46.2627.5158.97Price / Book1.595.496.255.90Net Income-$53.52M$33.37M$197.18M$258.50M7 Day Performance1.07%1.99%1.51%2.12%1 Month Performance-1.05%10.74%6.49%12.62%1 Year Performance-33.91%41.55%30.80%19.25% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging1.9393 of 5 stars$5.20-0.1%$9.50+82.9%-35.0%$300.05M$11.28M-5.77190News CoverageFNAParagon 28N/A$13.11+0.1%$12.75-2.7%+57.9%$1.10B$256.18M-17.71343,000High Trading VolumePLSEPulse Biosciences3.9584 of 5 stars$16.07+0.2%$22.00+36.9%-18.9%$1.08B$700K0.00140Positive NewsBLFSBioLife Solutions2.2726 of 5 stars$22.02+0.3%$31.17+41.5%-0.4%$1.05B$87.76M-75.93440News CoveragePositive NewsAnalyst ForecastTNDMTandem Diabetes Care4.2498 of 5 stars$15.75+1.0%$32.71+107.7%-63.7%$1.05B$982.95M-5.672,650MDXGMiMedx Group3.4061 of 5 stars$6.80+2.1%$12.50+83.8%-7.2%$1.00B$348.88M25.19870Positive NewsUpcoming EarningsINMDInMode3.779 of 5 stars$14.74+0.2%$18.54+25.8%-17.9%$931.70M$392.41M6.33480Upcoming EarningsSSIISS Innovations InternationalN/A$4.75-4.8%N/AN/A$919.60M$20.65M0.004Gap DownKMTSKestra Medical TechnologiesN/A$15.43+3.5%$27.50+78.2%N/A$792.32M$52.64M0.00300IRMDiRadimed4.9269 of 5 stars$58.07+0.9%$72.00+24.0%+18.0%$738.65M$73.24M37.46110Positive NewsUpcoming EarningsSIBNSiBone4.0617 of 5 stars$17.32+0.7%$22.50+29.9%+5.7%$738.18M$167.18M-27.06350News Coverage Related Companies and Tools Related Companies Paragon 28 Competitors Pulse Biosciences Competitors BioLife Solutions Competitors Tandem Diabetes Care Competitors MiMedx Group Competitors InMode Competitors SS Innovations International Competitors Kestra Medical Technologies Competitors iRadimed Competitors SiBone Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NNOX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
